Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease juvenile idiopathic arthritis
Phenotype C0042165|anterior uveitis
Sentences 9
PubMedID- 24347829 Recently, leflunomide was proven as both safe and efficacious for long-term therapy treating chronic anterior uveitis associated with juvenile idiopathic arthritis [10].
PubMedID- 20039849 Purpose: aim of the present study was to validate a statistical model to predict a severe course of anterior uveitis (au) in patients with juvenile idiopathic arthritis (jia).
PubMedID- 20656330 Objectives: to analyze the effectiveness of immunosuppressants and biological therapies in autoimmune posterior uveitis, chronic anterior uveitis associated with juvenile idiopathic arthritis, and macular edema.
PubMedID- 24377416 Tocilizumab for severe chronic anterior uveitis associated with juvenile idiopathic arthritis in a pediatric patient.
PubMedID- 21586097 Elevated laser flare values correlate with complicated course of anterior uveitis in patients with juvenile idiopathic arthritis.
PubMedID- 23828309 Leflunomide, a valid and safe drug for the treatment of chronic anterior uveitis associated with juvenile idiopathic arthritis.
PubMedID- 24931957 Objective: to investigate the risk factors for chronic anterior uveitis in patients with juvenile idiopathic arthritis (jia).
PubMedID- 24215803 We report a 6-year-old boy with anterior uveitis associated with juvenile idiopathic arthritis (jia) who underwent cataract extraction in his right eye.
PubMedID- 24938442 Chronic anterior uveitis affects 10-30 % of patients with juvenile idiopathic arthritis (jia) and is still a cause of blindness in childhood.

Page: 1